Company / Income Tax
Sonoma Pharmaceuticals, Inc. Income Tax History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$550.0K
FY2026
5-year range
-$332.0K / $713.0K
FY2022-FY2026
Trend
+380.6%
vs FY2025
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Income Tax changed +381% YoY in FY2026, a notable deviation from the 8-year average annual change of +377%.
Based on SEC 10-K filings.
$550,000 in FY2026 with a 5-year CAGR of +80.1%.
Increased from -$33,000 to $550,000 over the past 2 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +80.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +80.1%, indicating consistent growth.
- In FY2026, income tax increased 380.6% year-over-year.
- Peak income tax was recorded in FY2022.
- Lowest income tax in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $550.0K | +380.6% |
| FY2025 | -$196.0K | -493.9% |
| FY2024 | -$33.0K | +90.1% |
| FY2023 | -$332.0K | -146.6% |
| FY2022 | $713.0K | +2358.6% |
| FY2021 | $29.0K | -93.7% |
| FY2020 | $458.0K | +816.0% |
| FY2019 | $50.0K | +101.2% |
| FY2018 | -$4.3M | - |
| FY2017 | $0 | - |
As of FY2026 · SEC 10-K · Updated Jun 28, 2026